Effects of Dioscorea Yam Gruel on Blood Lipid Profiles in PCI Patients With Coronary Heart Disease

This randomized controlled trial investigated the effects of Dioscorea yam gruel on blood lipid levels in patients with coronary heart disease after percutaneous coronary intervention (PCI). A total of 72 eligible post-PCI patients were randomly assigned to the control group or the intervention group. Patients in the control group received standard post-procedural treatment and care. In addition to this standard regimen, those in the intervention group were provided with approximately 150 g of Dioscorea yam gruel daily as a partial dinner replacement for 12 consecutive weeks. Serum levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and body mass index (BMI) were measured at baseline, and at 8 weeks and 12 weeks of the intervention.

NCT Number	NCT07589036
Lead Sponsor	900th Hospital of PLA Joint Logistic Support Force
Conditions	Coronary Heart Disease (CHD), PCI
Enrollment	72 participants
Start Date	2024-01-10
Primary Completion	2025-03-15 (estimated)
Study Completion	2025-03-15 (estimated)
Updated on ClinicalTrials.gov	2026-05-18